2017 Spain Coagulation Reagent and Instrument Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

March 2017 | 400 pages | ID: S1DAF9C5D36EN
Venture Planning Group

Abstracts

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 400 pages,37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business and technological trends in the Spanish coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.Sales and Market Share Analysis

• Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

• Extensive strategic profiles ofmajor suppliers and emerging market entrants.

Market Segmentation Analysis

• Comprehensive marketsegmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Ambulatory Care Centers- Test volume forecasts for over 40 major proceduresby market segment.

Current and Emerging Products

• Review of established and emerging procedures.
• Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

• Analysis of current and emerging technologies and their potential market applications.
• Comprehensive lists of companies developingor marketing new technologies and products by test.

Strategic Recommendations

• Product development and business expansion opportunities with significant market appeal.
• Ideal product models with tentativeprices and operating characteristics.
• Alternative market penetrationstrategies for instrument and reagent suppliers.
• Potential market entry barriers and risks.

Contains 400 pages and 37 tables

Contents

1. INTRODUCTION

2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    a. Major Routine and Special COAGULATION TESTS
  1. INTRODUCTION
  2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  3. ALPHA  2 ANTIPLASMIN
  4. ANTITHROMBIN III
  5. BLEEDING TIME
  6. D  DIMER
  7. ETHANOL FLOCCULATION TEST
  8. EUGLOBULIN LYSIS
  9. FACTOR ASSAYS
    a. INTRODUCTION
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)

1. FACTOR XA

j. Factor XI
k. Factor XII
l. Factor XIII
  10. FIBRIN DEGRADATION PRODUCTS
  11. FIBRINOGEN
  12. HEPARIN
  13. HIRUDIN
  14. HYPERCOAGULABILITY AND THROMBOSIS
  15. LIPOPROTEIN A
  16. PLASMIN
  17. PLASMINOGEN
  18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
  19. PLATELET FUNCTION TESTS
  20. PLATELET AGGREGATION
  21. PROTEINS C AND S
  22. PROTHROMBIN FRAGMENT 1.2
  23. PROTHROMBIN TIME (PT)
  24. REPTILASE TIME
  25. THROMBIN TIME
  26. TISSUe TYPE PLASMINOGEN ACTIVATOR (T  PA)
  27. VON WILLEBRAND'S FACTOR
    b. INSTRUMENTATION Review
    c. Major in Vitr      Diagnostic Technologies and Their Potential Applications
  1. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
    c. Sequencing
    d. Microarrays/Biochips
  2. CHROMOGENIC SUBSTRATES
  3. MONOCLONAL AND POLYCLONAL ANTIBODIES
  4. IMMUNOASSAYS
  5. MICROCOMPUTERS
  6. AUTOMATION
  7. ROBOTICS
  8. ARTIFICIAL INTELLIGENCE
  9. DRY CHEMISTRY
  10. BIOSENSORS

3. SPAIN

    a. EXECUTIVE SUMMARY

    b. Business Environment
    c. Market Structure
    d. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares

4. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

5. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

6. ALTERNATIVE MARKET PENETRATION STRATEGIES

    a. Internal Development
    b. Collaborative Arrangements
    c. University Contracts
    d. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

7. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    a. Market Maturity
    b. Cost Containment
    c. Competition
    d. Technological Edge and Limitations
    e. Patent Protection
    f. Regulatory Constraints
    g. Decentralized Testing Market Challenges

8. COMPETITIVE ASSESSMENTS

  Abbott
  ADI/American Diagnostica
  Alere/Biosite/Inverness
  Axis  Shield
  Beckman Coulter/Danaher
  Becton Dickinson
  Bio/Data
  Chrono Log
  Corgenix Medical
  Diagnostica Stago/Trinity Biotech
  Grifols
  Helena Laboratories
  HYPEN BioMed
  INSTRUMENTATION Laboratory
  ITC/Nexus Dx
  Roche
  Siemens
  Sienco
  Sysmex
  ThermFischer
  ZyCare/Alere

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha  2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D  dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
EXECUTIVE SUMMARY Table: Spain, Total Coagulation Diagnostics Market By Market Segment and Product Category
Spain, Laboratories Performing COAGULATION TESTS By Market Segment
Spain, Hospital Laboratories Performing COAGULATION TESTS by Bed Size
Spain, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
Spain, Hospital Laboratories Average Daily Test Volume
Spain, Ambulatory Care Centers Average Daily Test Volume
Spain, Commercial/Private Laboratories Average Daily Test Volume
Spain, Total Coagulation Test Volume By Market Segment
Spain, All Market Segments Coagulation Test Volume
Spain, Hospital Laboratories Coagulation Test Volume
Spain, Ambulatory Care Centers Coagulation Test Volume
Spain, Commercial/Private Laboratories Coagulation Test Volume
Spain, Coagulation Reagent Market By Market Segment
Spain, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
Spain, Coagulation Instrument Market By Market Segment
Spain, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
Spain, Total Coagulation Diagnostics Market By Product Category
Spain, Major Suppliers of Coagulation Diagnostic Products, Estimates Sales and Market Shares